| 28.96 Data as of May 17 | -0.29 / -0.99%Today’s Change | 21.40 Today|||52-Week Range 31.15 | +15.47% Year-to-Date |
| Inside Business: NestlC) has time to unwrap L'OrC)al stake sale May 16 / FT.com | Aveo Screwed Up but Its Kidney Cancer Drug Is Real May 15 / TheStreet.com |
| India: Patents and precedents May 15 / FT.com | US earnings: irrational dreariness May 14 / FT.com |
| 5 Stocks Boosting The Drugs Industry Higher May 15 / TheStreet.com | Big Cap Pharma Is Turning Up May 14 / StockTwits |
| Pfizer Inc Stock Buy Recommendation Reiterated (PFE) May 15 / TheStreet.com | Stock Market News for May 14, 2013 - Market News May 14 / Zacks.com |
| Wider-Than-Expected Loss at Athersys - Analyst Blog May 15 / Zacks.com | Pfizer Inc (PFE): Today's Featured Drugs Winner May 13 / TheStreet.com |
| Previous close | 29.25 |
| Today’s open | 29.21 |
| Day’s range | 28.83 - 29.37 |
| Volume | 37,642,372 |
| Average volume (3 months) | 32,213,001 |
| Market cap | $205.4B |
| Dividend yield | 3.31% |
| Earnings growth (last year) | +17.43% |
| Earnings growth (this year) | +1.75% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | -12.52% |
| P/E ratio | 20.5 |
| Price/Sales | 3.16 |
| Price/Book | 2.59 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis AG | -0.86 | -1.15% |
| JNJJohnson & Johnson | +0.64 | +0.73% |
| SNYSanofi SA | +0.29 | +0.53% |
| MRKMerck & Co Inc | -0.38 | -0.82% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.58 |
| Annual revenue (last year) | $59.0B |
| Annual profit (last year) | $9.8B |
| Net profit margin | 16.09% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Ian C. Read |
President & General Manager-Emerging Markets Olivier Brandicourt, PhD, MD |
Corporate headquarters New York, New York |
